Skip to content

Air Polishing Effect on Biological, Clinical and Patient-reported Experience Among Epileptic and Non-epileptic Children

Effect of Air Polishing for Biofilm Removal on Clinical, Biological, and Patient-Reported Experience Among Epileptic and Non-Epileptic Children: A Split-Mouth Randomised Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06144034
Enrollment
20
Registered
2023-11-22
Start date
2022-03-01
Completion date
2023-06-28
Last updated
2023-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy, Gingivitis

Keywords

Air polishing, Airflow, Erythritol, Oral health of special healthcare needs children

Brief summary

In epileptic and non Epileptic children, the full dentition of each patient was split into four quadrants, starting from the upper right quadrant (1) and moving clockwise until the lower right quadrant (4). Bundled into two groups: quadrant (1+3) vs. (2+4). After randomization, each of these pairs of quadrants had the same treatment modality; test quadrants received treatment with airflow to remove soft biofilm, and ultrasonic scaler for areas with calculus deposits, and control quadrants were treated with conventional rubber cup polishing to remove soft biofilm and ultrasonic scaler for calculus deposits.

Detailed description

The treatment of each quadrant was administered sequentially, beginning with the upper right quadrant. Treatment duration was measured in seconds from the start of treatment in each quadrant until the removal of all disclosed biofilm and calculus. This process was repeated for each quadrant individually. And intra-oral photographs were taken before, immediately after treatment, and at follow-up time. Conventional treatment was conducted after biofilm disclosure by a rubber cup and prophylaxis paste spearmint (Kemdent Works, Purton. Swindon, Wiltshire. SN5 4HT, UK). The power setting was between 70% and 100%. The rubber cup was used until all biofilm was removed, then, if present, calculus was removed by Electro Medical Systems (EMS) ultrasonic scaler with a power setting between 3-6 on the Airflow control panel. For Airflow, treatment was conducted after biofilm disclosure. The powder chamber of the air polishing device was filled with low-abrasive erythritol powder, according to the manufacturer's instructions. The tip of the handpiece was positioned at an angle of 70° to the surface of the tooth to be polished at 3 mm from the tooth surface. Once activated, a non-stop movement from mesial to distal and distal to mesial in a smiley face shape starting from the gingival sulcus and moving upwards coronally to the incisal to cover the entire clinical crown was performed, with a power setting ranging from 3-6 on the control panel of the airflow device. EMS ultrasonic scaler was used to remove calculus if present with a power ranging from 3-6.

Interventions

Air polishing with erythritol powder utilized for biofilm disclosing and, followed by an ultrasonic scaler to remove calculus if present.

DEVICEConventional treatment

Rubber cup polishing with prophy paste after biofilm disclosing, followed by ultrasonic scaling of calculus if present.

Sponsors

King Abdullah University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Outcomes Assessor was blinded to treatment intervention

Intervention model description

Split-Mouth Design Clinical Trial

Eligibility

Sex/Gender
ALL
Age
5 Years to 15 Years
Healthy volunteers
Yes

Inclusion criteria

* children aged 5 to 15 years with epilepsy * on anti-epileptic drugs (AED) for at least 3 months * periodontal pockets depths not exceeding 3mm * full-mouth plaque scores over 50%, and having 5 teeth per quadrant. * The non-epileptic group included healthy non-epileptic children meeting similar criteria for age, periodontal health, and plaque scores

Exclusion criteria

* coexisting neurological illnesses other than epilepsy, medical conditions impacting oral health, periodontitis, asthma, swallowing difficulties, intellectual disabilities, and non-ambulatory status

Design outcomes

Primary

MeasureTime frameDescription
Gingival inflammationBefore treatment began, and two weeks after treatment.using Loe and Silness gingival index. Before biofilm disclosing, evaluated by assigning scores from 0-3 for gingival inflammation at four sites (mesial, distal, buccal, and lingual/palatal) per tooth, 0- normal gingiva and 3 - severely inflamed
Treatment durationfrom the time procedure begins until removing all dental biofilm and calculusfor each quadrant, time was measured from beginning of treatment till biofilm and calculus are fully removed per seconds
Pain measureimmediately after treatments of each quadrant.Faces pain scale-Revised 0-10, 0 no pain, 10 maximum pain
patient satisfactionimmediately after treatments of each quadrant.Likert Faces 5-points satisfaction scale, 0-4, 0 = Very dissatisfied. 4= Very satisficed
Mean Marginal PlaqueBefore treatment began, immediately after, and two weeks after treatment.O'Leary Plaque Index on 6 sites per tooth, 0= absence of plaque or 1= presence of plaque

Secondary

MeasureTime frameDescription
Residual plaque areaBefore treatment began, immediately after, and two weeks after treatment.Rustogi modified Navy plaque index
BiomarkersBefore treatment began, and two weeks after treatment.Gingival crevicular fluid samples IL-1B and MMP-8 two samples per patient, one for each treatment method

Countries

Jordan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026